Management of Symptomatic Carotid Artery Stenosis: From Dogma to Data
Description
This presentation will review current concepts of risk stratification and studies needed to advance optimal carotid stenosis decision making.
Cerebrovascular Disease*
Date: September 15, 2025
Time: 4:15 pm to 5:45 pm
Track: Traditional Special Interest Group (SIG)
Session Description
This session aims to provide important updates of interest to members of the American Neurological Association attending the Annual Meeting. Specifically, we will include a cross-section of contemporary and cutting-edge topics in stroke and brain health. The areas presented will include genetic and environmental risk factors for intracerebral hemorrhage, GLP-1 agonists: a promising drug in stroke prevention, and managing symptomatic carotid artery disease: using data over dogma.
These three areas reflect the research interests of many academic stroke neurologists attending the ANA’s Annual Meeting. As a result, we anticipate strong attendance and expect the session to highlight the most up-to-date science from three leading experts in the field.
Additionally, we will feature the two best abstracts submitted to the Annual Meeting in two podium presentations. A third presentation slot will be dedicated to an early career abstract submission—from a trainee, Instructor, or Assistant Professor—to provide an opportunity for emerging researchers to present their work during the session. This initiative is intended to encourage future submissions from early career investigators and to foster ongoing involvement in the ANA throughout their academic careers.
Learning Objectives
At the conclusion of this session, attendees should be able to:
- Describe key environmental and genetic risk factors for intracerebral hemorrhage.
- Discuss the benefits of GLP-1 agonists in cardiovascular risk reduction and stroke prevention.
- Summarize core treatment strategies for symptomatic carotid artery disease.
Speakers
Genetic and Environmental Risk Factors for Intracerebral Hemorrhage
Description
This presentation will provide an update on the complex interaction between genetics and environmental risk factors on cerebral small vessel disease and intracerebral hemorrhage in particular.
Speakers
GLP 1 Agonists - A Promising Drug in Stroke Prevention
Description
This presentation will review the data on GLP1 agonists and DM, CVD and chronic health outcomes, and their role in stroke prevention.